These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17975981)

  • 21. Experimental intraprostatic injection of bacillus Calmette-Guerin: a feasibility and safety study.
    Kosecka U; Sowery RD; Morales A
    J Urol; 2005 Mar; 173(3):996-9. PubMed ID: 15711364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors.
    Spugnini EP; Vincenzi B; Baldi F; Citro G; Baldi A
    Anticancer Res; 2006; 26(6B):4585-9. PubMed ID: 17201181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and safety of a water-soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas.
    Rivera P; Akerlund-Denneberg N; Bergvall K; Kessler M; Rowe A; Willmann M; Persson G; Kastengren Fröberg G; Westberg S; von Euler H
    J Small Anim Pract; 2013 Jan; 54(1):20-7. PubMed ID: 23190121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment.
    Okamura T; Akita H; Imura M; Kaneko T; Mizuno K; Tozawa K; Kohri K
    Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
    BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.
    Rassnick KM; Al-Sarraf R; Bailey DB; Chretin JD; Phillips B; Zwhalen CH
    Vet Comp Oncol; 2010 Jun; 8(2):103-11. PubMed ID: 20579323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
    Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
    J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy.
    Skolarus TA; Lee EW; Virgo KS; Katz MD; Hudson MA; Kibel AS; Grubb RL
    J Am Coll Surg; 2009 Aug; 209(2):248-53. PubMed ID: 19632602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The present status of BCG treatment in the veterinary practice.
    Klein WR; Rutten VP; Steerenberg PA; Ruitenberg EJ
    In Vivo; 1991; 5(6):605-8. PubMed ID: 1810446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer: an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?
    Damiano R; De Sio M; Quarto G; Di Lorenzo G; Perdonà S; Palumbo IM; Azzarito G; Giugliano F; Autorino R
    BJU Int; 2009 Sep; 104(5):633-9. PubMed ID: 19298412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
    Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A
    BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
    Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I
    J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Elders RC; Baines SJ; Catchpole B
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):11-6. PubMed ID: 19185923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
    Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
    J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.
    Bisiaux A; Thiounn N; Timsit MO; Eladaoui A; Chang HH; Mapes J; Mogenet A; Bresson JL; Prié D; Béchet S; Baron C; Sadorge C; Thomas S; Albert EB; Albert PS; Albert ML
    J Urol; 2009 Apr; 181(4):1571-80. PubMed ID: 19230924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma.
    Agrawal MS; Agrawal M; Bansal S; Agarwal M; Lavania P; Goyal J
    Urology; 2007 Dec; 70(6):1075-8. PubMed ID: 18158020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
    Welle MM; Bley CR; Howard J; Rüfenacht S
    Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of buffy coat smears for circulating mast cells in healthy cats and ill cats without mast cell tumor-related disease.
    Garrett LD; Craig CL; Szladovits B; Chun R
    J Am Vet Med Assoc; 2007 Dec; 231(11):1685-7. PubMed ID: 18052803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.